Page 622 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPTEr 42 Urticaria, Angioedema, and Anaphylaxis 599

Please check your eBook at https://expertconsult.inkling.com/ 25. Simons FE, Ardusso LR, Bilò MB, et al. International consensus on
for self-assessment questions. See inside cover for registration (ICON) anaphylaxis. World Allergy Organ J 2014;7(1):9.
details. 26. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis – a practice
parameter update 2015. Ann Allergy Asthma Immunol 2015;115:341–84.
27. Muraro A, Roberts G, Worm M, et al. EAACI Food Allergy and
REFERENCES Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the
European Academy of Allergy and Clinical Immunology. Allergy
1. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO 2014;69:1026–45.
Guideline for the definition, classification, diagnosis, and management of 28. Simons FE, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the
urticaria: the 2013 revision and update. Allergy 2014;69:868–87. evidence base: World Allergy Organization anaphylaxis guidelines. World
2. Greaves MW, Kaplan A, editors. Urticaria and angioedema. New York: Allergy Organ J. 2015;8:32.
Marcel Dekker; 2004. 29. Tejedor Alonso MA, Moro Moro M, Múgica García MV. Epidemiology of
3. Beltrani VS. An overview of chronic urticaria. Clin Rev Allergy Immunol anaphylaxis. Clin Exp Allergy 2015;45:1027–39.
2002;23:147–69. 30. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and
4. Asero R. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma management of anaphylaxis practice parameter: 2010 update. J Allergy
Immunol 2002;89:195–6. Clin Immunol 2010;126(3):477–80.
5. O’Donnell BF, O’Neill CM, Francis DM, et al. Human leucocyte antigen 31. Panesar SS, Javad S, de Silva D, et al. EAACI Food Allergy and
class II associations in chronic idiopathic urticaria. Br J Dermatol Anaphylaxis Group. The epidemiology of anaphylaxis in Europe: a
1999;140:853–8. systematic review. Allergy 2013;68:1353–61.
6. Kim SH, Choi JH, Lee KW, et al. The human leucocyte antigen-DRB 32. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found
1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic Symp 2004;257:116–28.
marker for aspirin-induced urticaria. Clin Exp Allergy 2005;35: 33. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, et al. Anaphylaxis in
339–44. children and adolescents: The European Anaphylaxis Registry. J Allergy
7. Maurer M, Metz M. The status quo and quo vadis of mast cells. Exp Clin Immunol 2016;137:1128–37.
Dermatol 2005;14:923–9. 34. Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related
8. Church MK, el-Lati S, Caulfield JP. Neuropeptide-induced secretion from hospitalizations but no increase in fatalities: an analysis of United
human skin mast cells. Int Arch Allergy Appl Immunol 1991;94:310–18. Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol
9. Sabroe RA, Greaves MW. Chronic idiopathic urticaria with functional 2015;135:956–63.
autoantibodies: 12 years on. Br J Dermatol 2006;154:813–19. 35. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of
10. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin life-threatening and lethal anaphylaxis: a review. Allergy
Immunol 2004;114:465–74. 2005;60(4):443–51.
11. Puccetti A, Bason C, Simeoni S, et al. In chronic idiopathic urticaria 36. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy
autoantibodies against FcεRII/CD23 induce histamine release via 2003;33(8):1033–40.
eosinophil activation. Clin Exp Allergy 2005;35:1599–607. 37. Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF
12. Zuberbier T. The role of allergens and pseudoallergens in urticaria. J acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008;358:28–35.
Investig Dermatol Symp Proc 2001;6:132–4. 38. Valent P. Risk factors and management of severe life-threatening
13. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol anaphylaxis in patients with clonal mast cell disorders. Clin Exp Allergy
2003;28:123–7. 2014;44:914–20.
14. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and 39. Bonadonna P, Pagani M, Aberer W, et al. Drug hypersensitivity in
current and future treatment options. Drugs 2004;64:2515–36. clonal mast cell disorders: ENDA/EAACI position paper. Allergy
15. Buhner S, Reese I, Kuehl F, et al. Pseudoallergic reactions in chronic 2015;70:755–63.
urticaria are associated with altered gastroduodenal permeability. Allergy 40. Greenberger PA, Lieberman P. Idiopathic anaphylaxis. J Allergy Clin
2004;59:1118–23. Immunol Pract 2014;2(3):243–50.
16. Wanderer AA, Hoffman HM. The spectrum of acquired and familial 41. Wolbing F, Fisher J, Koberle M, et al. About the role and underlying
cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin mechanisms of cofactors in anaphylaxis. Allergy 2013;68:1085–92.
North Am 2004;24:259–86. 42. Umasunthar T, Leonardi-Bee J, Turner PJ, et al. Incidence of food
17. Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic anaphylaxis in people with food allergy: a systematic review and
urticarial vasculitis syndrome. Immunol Allergy Clin North Am meta-analysis. Clin Exp Allergy 2015;45:1621–36.
2004;24:183–213. 43. International Collaborative Study of Severe Anaphylaxis. Risk of
18. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and anaphylaxis in a hospital population in relation to the use of various
approach to treatment for angioedema: consensus report from the drugs: an international study. Pharmacoepidemiol Drug Saf
Hereditary Angioedema International Working Group. Allergy 2003;12(3):195–202.
2014;69:602–16. 44. Galvão VR, Castells MC. Hypersensitivity to biological agents-updated
19. Simon A, Asli B, Braun-Falco M, et al. Schnitzler’s syndrome: diagnosis, diagnosis, management and treatment. J Allergy Clin Immunol Pract
treatment, and follow-up. Allergy 2013;68:562–8. 2015;3(2):175–85.
20. Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic 45. Steinke JW, Platts-Mills TA, Commins SP. The alpha-gal story: lessons
syndromes and autoinflammation. Clin Exp Dermatol 2008;33:1–9. learned from connecting the dots. J Allergy Clin Immunol
21. Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified 2015;135(3):589–96.
diagnoses in patients with physical and chronic urticaria and 46. Weiss WE, Adkinson NF. Immediate hypersensitivity reactions to
angioedema: a systematic review. J Am Acad Dermatol 2003;48:409–16. penicillin and related antibiotics. Clin Allergy 1988;18:515–40.
22. Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing 47. Reitter M, Petitpain N, Latarche C, et al. French network of regional
and management of chronic inducible urticarias - update and revision of pharmacovigilance centres. Fatal anaphylaxis with neuromuscular
the EAACI/GA(2)LEN/EDF/UNEV 2009 consensus panel blocking agents: a risk factor and management analysis. Allergy
recommendations. Allergy 2016;71:780–802. 2014;69:954–9.
23. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin 48. Rutkowski K, Wagner A. Chlorhexidine: a new latex? Eur Urol
test: a screening test for autoantibodies in chronic idiopathic urticaria. 2015;68:345–7.
Br J Dermatol 1999;140:446–52. 49. Golden DB, Moffitt J, Nicklas RA, et al, Joint Task Force on Practice
24. Zuraw BL. Hereditary angioedema. N Engl J Med 2008;359:1027–36. Parameters; American Academy of Allergy, Asthma & Immunology